Review
Copyright ©The Author(s) 2025.
World J Nephrol. Jun 25, 2025; 14(2): 99380
Published online Jun 25, 2025. doi: 10.5527/wjn.v14.i2.99380
Table 1 Molecular characteristics of paediatric renal tumors
Renal tumor
Molecular feature
Paediatric cystic nephromaDICER1 mutation[12]
Metanephric adenomaBRAFV600E mutation[25]; KANK1::NTRK3 gene fusion in BRAF negative cases[26]
Metanephric stromal tumorBRAFV600E mutation[32]
Metanephric adenofibromaBRAFV600E mutation[35]
Ossifying renal tumor of infancyClonal trisomy 4[39]
MN(1) Cellular MN: t(12;15)(p13;q25) resulting in fusion of ETV6 and NTRK3 genes[45]; (2) Classic MN: EGFR ITD[47] (3) Mixed MN: Either EGFR ITD or ETV6::NTRK3 gene fusion[47]
Nephroblastoma (Wilms tumor)Genetic changes in WT1, CTNNB1, IGF2, TP53, MYCN genes and 1q gain[56]
Malignant rhabdoid tumor of the kidneyBiallelic inactivation of SMARCB1/INI1[65]
Clear cell sarcoma of the kidney(1) BCOR-ITD exon 15[74]; (2) YWHAE: NUTM2 gene fusion[76]; (3) BCOR::CCNB3 gene fusion[75]
Anaplastic sarcoma of the kidneyDICER 1 and RNAase IIIb mutation[82]
Renal Ewing sarcoma(1) t(11;22)(q24;q12) resulting EWSR1-FLI1 fusion[89]; (2) t(21;22)(q22;q12) resulting in EWSR1-ERG fusion[90]
Renal cell carcinoma with MiT translocationsTFE3 rearranged RCCs-fusion of TFE3 with other genes like ASPL, PRCC, PSF, CLTC[93]; TFEB rearranged RCCs-MALAT1 (Alpha)::TFEB fusion[94]
ALK-rearranged renal cell carcinomasVCL-ALK fusion[98]; TPM3-ALK fusion [97]; Rarely STRN-ALK, EML4-ALK, HOOK1-ALK fusions[96,99]
Eosinophilic solid and cystic renal cell carcinomaBiallelic somatic mutations of TSC1 or TSC2 genes[106]
SMARCB1-deficient renal medullary carcinomaInactivation of SMARCB1 gene[112]